Dr. Stuart K. Williams II received his Ph.D. in Cell Biology from the University of Delaware, followed by postdoctoral training in Pathology at Yale School of Medicine. From 1980 to 1990, he held a faculty appointment at Jefferson Medical College, where he served as Director of Research in the Department of Surgery.
In 1990, Dr. Williams joined the University of Arizona, where he founded the Biomedical Engineering Program—bridging research and education between the College of Engineering and the Medical School. He held joint faculty appointments in Biomedical Engineering, Surgery, Physiology, and Materials Science and Engineering.
In 2007, Dr. Williams was appointed Director of the newly established Cardiovascular Innovation Institute—a collaborative initiative between Jewish Hospital and the University of Louisville. There, he launched the Bioficial Organs Program, focused on developing functional human tissues and organs using a patient’s own cells. Central to this work is the use of advanced 3D bioprinting technologies for both therapeutic applications and in vitro drug testing. In 2020, Dr. Williams began collaborating with Orgenesis, Inc.
Dr. Williams’ research spans medical devices and regenerative medicine, and he is credited with developing and patenting the first therapeutic methods using fat-derived stem and regenerative cells. He has authored more than 300 scientific publications and holds 30 issued U.S. patents, with numerous others pending. A serial entrepreneur, he has founded six biotechnology companies and has served in leadership and advisory roles across the medical device, regenerative medicine, and pharmaceutical industries.
Dr. Williams is a Fellow of the American Heart Association and the American Institute of Medical and Biological Engineering, reflecting his enduring contributions to both science and clinical innovation.
